These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. Ballas SK; Kesen MR; Goldberg MF; Lutty GA; Dampier C; Osunkwo I; Wang WC; Hoppe C; Hagar W; Darbari DS; Malik P ScientificWorldJournal; 2012; 2012():949535. PubMed ID: 22924029 [TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of chronic organ damage in adult sickle cell patients: A seven-year follow-up study. van Tuijn CFJ; Schimmel M; van Beers EJ; Nur E; Biemond BJ Am J Hematol; 2017 Oct; 92(10):E584-E590. PubMed ID: 28699283 [TBL] [Abstract][Full Text] [Related]
8. Sickle cell disease clinical phenotypes in children from South-Western, Nigeria. Adegoke SA; Adeodu OO; Adekile AD Niger J Clin Pract; 2015; 18(1):95-101. PubMed ID: 25511352 [TBL] [Abstract][Full Text] [Related]
9. Transition to adult care in sickle cell disease: A longitudinal study of clinical characteristics and disease severity. Kayle M; Docherty SL; Sloane R; Tanabe P; Maslow G; Pan W; Shah N Pediatr Blood Cancer; 2019 Jan; 66(1):e27463. PubMed ID: 30251318 [TBL] [Abstract][Full Text] [Related]
10. Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non- Sickle dialysis patients. Nielsen L; Canouï-Poitrine F; Jais JP; Dahmane D; Bartolucci P; Bentaarit B; Gellen-Dautremer J; Remy P; Kofman T; Matignon M; Suberbielle C; Jacquelinet C; Wagner-Ballon O; Sahali D; Lang P; Damy T; Galactéros F; Grimbert P; Habibi A; Audard V Br J Haematol; 2016 Jul; 174(1):148-52. PubMed ID: 26992059 [TBL] [Abstract][Full Text] [Related]
11. Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients. Bartolucci P; Habibi A; Khellaf M; Roudot-Thoraval F; Melica G; Lascaux AS; Moutereau S; Loric S; Wagner-Ballon O; Berkenou J; Santin A; Michel M; Renaud B; Lévy Y; Galactéros F; Godeau B EBioMedicine; 2016 Aug; 10():305-11. PubMed ID: 27412264 [TBL] [Abstract][Full Text] [Related]
12. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India. Nishank SS; Singh MP; Yadav R Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124 [TBL] [Abstract][Full Text] [Related]
13. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease. Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790 [TBL] [Abstract][Full Text] [Related]
14. Emergency Medicine Management of Sickle Cell Disease Complications: An Evidence-Based Update. Simon E; Long B; Koyfman A J Emerg Med; 2016 Oct; 51(4):370-381. PubMed ID: 27553919 [TBL] [Abstract][Full Text] [Related]
15. Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population). Elshazly SA; Heiba NM; Abdelmageed WM Hematology; 2014 Jan; 19(1):52-9. PubMed ID: 23735470 [TBL] [Abstract][Full Text] [Related]
16. CT abdominal imaging findings in patients with sickle cell disease: acute vaso-occlusive crisis, complications, and chronic sequelae. Gardner CS; Boll DT; Bhosale P; Jaffe TA Abdom Radiol (NY); 2016 Dec; 41(12):2524-2532. PubMed ID: 27600384 [TBL] [Abstract][Full Text] [Related]
17. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy. Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148 [TBL] [Abstract][Full Text] [Related]